MedTrace Logo

CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study

NCT03786263 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2019-05-06

No results posted yet for this study

Summary

CHILDNEPH is a pan-Canadian project to observe clinical care for children with nephrotic syndrome. Previous studies have indicated that there is wide practice variation in how health care providers treat this remitting and relapsing disease of childhood. The disease mechanism is not yet understood, and long-term use of steroids can affect children's health. This study involves assessment of routine clinical care and establishing a long-term patient registry for children with nephrotic syndrome.

Conditions

  • Nephrotic Syndrome in Children
  • Nephrotic Syndrome, Minimal Change
  • Nephrotic Syndrome，Idiopathic

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Susan Samuel, MD, MSc · University of Calgary

Eligibility

Min Age
1 Year
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-03
Primary Completion
2020-06-30
Completion
2022-03-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03786263 on ClinicalTrials.gov